Research and Clinical Trials

Title  

STRIIVING (ViiV Healthcare 201147

Brief Description  

The purpose of this study is to determine the safety and efficacy of an experimental drug, abacavir/dolutegravir/lamivudine (ABC/DTG/3TC) fixed dose combination as a single tablet regimen compared with subjects taking their current combined antiretroviral therapy (cART) for the treatment of HIV-1 infected adults in whom the HIV-1 virus is currently suppressed

Who may be Eligible  

Adults 18 or older; Agree not to become pregnant or father a child during the study term; Have an HIV viral load <50 for past 2 visits; Have been on current regimen for >6 months; Have stable maintenance labs; Not be on Dolutegravir (Tivicay) or Etravirine (Intelence); Normal EKG

Speciality/Disorder  

HIV

Start Date  

07/31/2014

IRB Number  

C-185

Principal Investigator  

Johnson, Marc

Contact Name  

Jessica

For More Information, Contact  Jessica  A, Kearney-Bryan
Phone:  (704) 355-0244  Fax:  (704) 446-7641  
Email:  Jessica.kearney-bryan@carolinas.org
Address:3rd Floor Myer's Park Clinic 1350 S. Kings Drive Charlotte, NC 28207